Susquehanna Portfolio Strategies Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$63.7M |
| 2 |
Pfizer
PFE
|
+$63.5M |
| 3 |
Equinix
EQIX
|
+$55.4M |
| 4 |
Starbucks
SBUX
|
+$54.1M |
| 5 |
Apple
AAPL
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manulife Financial
MFC
|
+$7.89M |
| 2 |
PG&E
PCG
|
+$5.39M |
| 3 |
Blackstone
BX
|
+$3.1M |
| 4 |
JWN
Nordstrom
JWN
|
+$2.04M |
| 5 |
Albertsons Companies
ACI
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.19% |
| 2 | Financials | 16.3% |
| 3 | Healthcare | 13.62% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Industrials | 11.13% |
Similar funds
Susquehanna Portfolio Strategies's Q2 2025 Portfolio in Review
As of Q2 2025, Susquehanna Portfolio Strategies held 855 positions worth $4.58B, up 1,869% from $233M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Susquehanna Portfolio Strategies deployed $4.06B of net new capital in Q2 2025, opening 695 new positions and adding to 118 existing holdings. Its largest new stake was Merck: 800,753 shares worth $63.4M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Manulife Financial, an estimated $7.89M trimmed.
- Susquehanna Portfolio Strategies's largest Q2 2025 buy was Merck: 800,753 shares worth $63.4M.
- Susquehanna Portfolio Strategies added most to Blackrock in Q2 2025, an estimated $53.7M increase.
- Susquehanna Portfolio Strategies's biggest Q2 2025 reduction was Manulife Financial, cutting an estimated $7.89M.
- Susquehanna Portfolio Strategies fully exited Blackstone in Q2 2025, selling an estimated $3.1M.
- Susquehanna Portfolio Strategies's ten largest holdings make up 13% of its $4.58B portfolio in Q2 2025.
- Susquehanna Portfolio Strategies opened 695 new positions and closed 24 in Q2 2025.
- Susquehanna Portfolio Strategies's portfolio value rose 1,869% quarter-over-quarter to $4.58B.
Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.